loading
前日終値:
$4.65
開ける:
$4.67
24時間の取引高:
32,750
Relative Volume:
0.63
時価総額:
$3.35M
収益:
$5.49M
当期純損益:
$-6.35M
株価収益率:
-0.8809
EPS:
-5.29
ネットキャッシュフロー:
$-6.51M
1週間 パフォーマンス:
+8.86%
1か月 パフォーマンス:
-26.96%
6か月 パフォーマンス:
-33.98%
1年 パフォーマンス:
-38.68%
1日の値動き範囲:
Value
$4.59
$4.97
1週間の範囲:
Value
$3.65
$4.99
52週間の値動き範囲:
Value
$2.414
$15.70

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Name
名前
Inmed Pharmaceuticals Inc
Name
セクター
Healthcare (1195)
Name
電話
(604) 669-7207
Name
住所
1445-885 WEST GEORGIA ST., VANCOUVER
Name
職員
13
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
INM's Discussions on Twitter

INM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
INM 4.66 3.35M 5.49M -6.35M -6.51M -5.29
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Inmed Pharmaceuticals Inc (INM) 最新ニュース

pulisher
Nov 21, 2024

InMed Pharmaceuticals (FRA:MWG) EBITDA : €-6.11 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (FRA:MWG) Book Value per Share : €11.34 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Accounts Receivable : €0.26 Mil (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Pre-Tax Income : €-6.25 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Days Inventory : 147.82 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) GF Score : 43/100 (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Earnings per Share (Diluted) : €-59.16 (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Median PS Value : €0.00 (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Asset Turnover : 0.11 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Net Income From Continuing Operations : €-6.25 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cost of Goods Sold : €3.11 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Intrinsic Value: DCF (Earni - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Free Cash Flow : €-6.08 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) COGS-to-Revenue : 0.61 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cash Flow from Operations : €-6.08 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Earnings Yield (Joel Greenb - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Net-Net Working Capital : €5.86 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Quick Ratio : 4.22 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Debt-to-Revenue : 0.21 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Price-to-Owner-Earnings : (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cash-to-Debt : 5.28 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted PB Rati - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cash Flow for Dividends : €0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted FCF per Share : €-485.97 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Price-to-Free-Cash-Flow : N/A (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted Book pe - GuruFocus.com

Nov 21, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted PS Rati - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Inventories, Finished Goods : €0.84 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) 3-Year Book Growth Rate : -64.40% (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Current Liabilities : €0.21 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EPS (Basic) : €-59.16 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Long-Term Liabilities : €0.00 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Purchase Of Business : €0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Long Term Assets : €0.09 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash Ratio : 3.89 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash Flow from Investing : €-0.01 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EBIT : €-6.66 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (FRA:MWG) Peter Lynch Fair Value : €-1,493.15 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash From Other Investing A - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Long-Term Capital Lease Obl - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Total Stockholders Equity : €7.56 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EV-to-EBITDA : 0.22 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted Revenue per Share : €68.91 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Purchase Of Investment : €-0.04 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Change In Receivables : €-0.11 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) 3-Year EPS without NRI Grow - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Issuance of Debt : €0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

Inmed Pharmaceuticals Inc (INM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):